Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
12.61
+1.01 (8.71%)
Aug 19, 2026, 9:57 AM EDT - Market open
Intellia Therapeutics Market Cap
Intellia Therapeutics has a market cap or net worth of $1.77 billion as of August 19, 2026. Its market cap has increased by 53.41% in one year.
Market Cap
1.77B
Enterprise Value
1.21B
1-Year Change
53.41%
Ranking
Category
Stock Price
$12.61
ChartMarket Cap Chart
Since May 6, 2016, Intellia Therapeutics's market cap has increased from $757.50M to $1.77B, an increase of 133.27%. That is a compound annual growth rate of 8.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 1.77B | 69.69% |
| Dec 31, 2025 | 1.04B | -12.32% |
| Dec 31, 2024 | 1.19B | -56.51% |
| Dec 29, 2023 | 2.73B | -0.54% |
| Dec 30, 2022 | 2.75B | -68.80% |
| Dec 31, 2021 | 8.80B | 173.78% |
| Dec 31, 2020 | 3.21B | 348.19% |
| Dec 31, 2019 | 717.10M | 20.99% |
| Dec 31, 2018 | 592.70M | -14.55% |
| Dec 29, 2017 | 693.60M | 46.98% |
| Dec 30, 2016 | 471.90M | -37.70% |
| May 6, 2016 | 757.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immunocore Holdings | 1.76B |
| Avalyn Pharma | 1.74B |
| Xencor | 1.74B |
| Braveheart Bio | 1.73B |
| AnaptysBio | 1.73B |
| Recursion Pharmaceuticals | 1.69B |
| Ascentage Pharma Group International | 1.69B |
| Fortrea Holdings | 1.66B |